1. Home
  2. DDS vs NUVL Comparison

DDS vs NUVL Comparison

Compare DDS & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dillard's Inc.

DDS

Dillard's Inc.

HOLD

Current Price

$569.55

Market Cap

9.5B

ML Signal

HOLD

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$97.48

Market Cap

7.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DDS
NUVL
Founded
1938
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Department/Specialty Retail Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.5B
7.8B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
DDS
NUVL
Price
$569.55
$97.48
Analyst Decision
Sell
Strong Buy
Analyst Count
3
15
Target Price
$519.67
$135.33
AVG Volume (30 Days)
112.1K
441.5K
Earning Date
02-24-2026
05-07-2026
Dividend Yield
5.28%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$0.99
N/A
Revenue Next Year
$1.09
$1,064.25
P/E Ratio
$18.08
N/A
Revenue Growth
N/A
N/A
52 Week Low
$282.24
$55.54
52 Week High
$741.98
$113.02

Technical Indicators

Market Signals
Indicator
DDS
NUVL
Relative Strength Index (RSI) 38.71 41.83
Support Level $519.06 $73.22
Resistance Level $634.02 $107.13
Average True Range (ATR) 23.55 3.39
MACD -0.59 -0.38
Stochastic Oscillator 5.10 26.94

Price Performance

Historical Comparison
DDS
NUVL

About DDS Dillard's Inc.

Dillard's Inc is an American fashion apparel, cosmetics, and home furnishings retailer. Its stores offer a large variety of merchandise and feature products from both national and exclusive brand sources. The company also operates a general contracting construction company, CDI Contractors. CDI Contractors' business includes constructing and remodelling stores for Dillards. The merchandise selections include exclusive brand merchandise such as Antonio Melani, Gianni Bini, Daniel Cremieux, Roundtree & Yorke, and private-label merchandise, among others. The company operates in two business segments; Retail Operations and Construction. The Retail Operations segment generates maximum revenue for the company.

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of its operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

Share on Social Networks: